Restoc is an intelligence platform for clinical capital allocation in dentistry —
helping practices decide what to buy, standardize, and invest in with confidence, not guesswork.
Target: 15–18 min
Private demo utility (noindex)
Live Pages
Optional
Investor access code (for smooth dashboard demo)
If provided, we’ll generate links as ?code=... for /investor and /dashboard.
Playbook: explain why this is capital intelligence (protocols, not discounts).
Investor → Dashboard: show aggregated signals: capital leaks + protocol demand.
Script line: “Every case allocates capital — chair time, staff effort, rework risk. Restoc turns case discussions into protocols and standard kits.”
Interview Script (15–18 min)
Framing (30s)
“This isn’t a sales demo. I’m trying to understand how dentists decide where to invest money, time, and trust — not just products, but skills and systems.”
1) Capital allocation baseline (4 min)
When improving the practice, what do you invest in first (supplies, tech, CE, staff)?
How do you decide if something is “worth it” before committing?
Where do you feel least confident — pricing, outcomes, or choosing what to invest in?
2) Peer intelligence signal (5 min)
Would knowing what similar clinics use change how you evaluate a product or course?
Would that matter more for supplies or for CE/skills?
Have you ever taken CE mainly because “everyone else was doing it”?
3) Pathway & CE test (4 min)
How do you decide which CE is actually worth your time?
Do you treat CE as an expense or an investment?
If skills/courses were linked to outcomes or profitability, would that change your choices?
4) Group-buy reframed as standardization (3 min)
Would you trust a group-buy more if framed as “clinical consensus & standardization,” not discounts?
What would make it feel legitimate vs gimmicky?
5) Case-to-protocol (optional, 90s)
Which procedures feel least standardized (implant/GBR, endo emergencies, adhesive deep margins, perio surgery)?
Where do cases leak the most capital: diagnosis uncertainty, execution variance, materials variance, team variability, or vendor logistics?
If you could turn case discussions into a protocol + standard kit, would that reduce rework?
Keep it clean: no PHI, no “AI diagnosis.” This is decision checkpoints and variance reduction.
Close (2 min)
Would you want early access if this becomes real?
Can I follow up in a couple months?
Is there anyone else I should talk to?
Post-call capture (60s)
Best quote (verbatim): __________________________
Biggest pain: __________________________
Strongest objection: __________________________
Pilot willingness: Yes / Maybe / No
Tip: After each interview, capture the single best quote verbatim — it becomes your strongest PMF and investor proof.